TPIAO (Recombinant Human Thrombopoietin)

TPIAO (Recombinant Human Thrombopoietin) is a bioengineered form of the natural human thrombopoietin, a critical growth factor that regulates platelet production in the body. This medication is primarily used for the prevention and treatment of thrombocytopenia (low platelet count), particularly in patients receiving chemotherapy for malignant tumors. It may also be considered in other clinical conditions where platelet production is impaired.

Main Uses:

• Chemotherapy-induced thrombocytopenia
• Thrombocytopenia secondary to bone marrow suppression
• Supportive therapy in platelet-deficient conditions

Contraindications:

• Known hypersensitivity to recombinant human thrombopoietin or formulation components
• Use with caution in patients with hematologic malignancies, myelodysplastic syndromes, or those at risk for thrombosis or excessive platelet production
• Regular monitoring of platelet counts is recommended during therapy

Dosage: The dosage of this medicine depends on the prescription and instruction given by the doctor.

Precautions: Do not take this medicine without any medical consultation with your doctor.